Southborough, MA, United States of America

William C DeWolf

This inventor holds 2 USPTO granted patents. Top assignees: Whitehead Institute for Biomedical Research, Beth Israel Hospital, The Beth Israel Hospital Association. Active years: 1997-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William C DeWolf. Retrieved from https://idiyas.com/inventor/william-c-dewolf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1997-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of William C. DeWolf

Introduction

William C. DeWolf is an accomplished inventor based in Southborough, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of vaccines. With a total of 2 patents, his work has the potential to impact public health positively.

Latest Patents

DeWolf's latest patents focus on recombinant mycobacterial vaccines. The first patent relates to recombinant mycobacteria, specifically recombinant M. bovis BCG, which express heterologous DNA encoding a product of interest, such as a protein or polypeptide that elicits an immune response. The second patent also pertains to recombinant BCG, emphasizing the expression of heterologous DNA for similar purposes. These innovations aim to enhance vaccine efficacy and improve immune responses.

Career Highlights

Throughout his career, DeWolf has worked with prestigious institutions, including the Whitehead Institute for Biomedical Research and Beth Israel Hospital. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of DeWolf's notable coworkers include Michael A. O'Donnell and Rosemary B. Duda. Their collaborative efforts have further advanced the research and development of innovative biomedical solutions.

Conclusion

William C. DeWolf's contributions to the field of biomedical research through his patents and collaborations highlight his commitment to advancing healthcare solutions. His work in recombinant mycobacterial vaccines represents a significant step forward in vaccine technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…